Circulating Levels of TNF Receptor II Are Prognostic for Patients With Peripheral T-Cell Non-Hodgkin Lymphoma

Clinical Cancer Research- United States

doi 10.1158/1078-0432.ccr-11-3299

Full Text

Abstract

Available in

Date

Authors

Publisher

American Association for Cancer Research (AACR)

Related search

Prognostic Markers in Peripheral T-Cell Lymphoma

Current Hematologic Malignancy Reports
Cancer ResearchOncologyHematology
2010English

Prognostic Value of Interim Positron Emission Tomography in Patients With Peripheral T-Cell Lymphoma

Oncologist
Cancer ResearchMedicineOncology
2014English

The Prognostic Significance of Elevated Levels of Serum Ferritin Before Chemotherapy in Patients With Non-Hodgkin Lymphoma

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2014English

Comorbidity as an Independent Prognostic Factor in Elderly Patients With Peripheral T-Cell Lymphoma

OncoTargets and Therapy
OncologyPharmacology
2016English

Management of Patients With Non-Hodgkin’s Lymphoma: Focus on Adoptive T-Cell Therapy

ImmunoTargets and Therapy
AllergyImmunology
2015English

Prognostic Factors in HIV-positive Patients With Non-Hodgkin Lymphoma: A Peruvian Experience

Infectious Agents and Cancer
Cancer ResearchEpidemiologyOncologyInfectious Diseases
2018English

Autologous Peripheral Blood Stem Cell Transplantation in Children and Adolescents With Non‑Hodgkin Lymphoma

Oncology Letters
Cancer ResearchOncology
2015English

Circulating Microparticles Are Prognostic Biomarkers in Advanced Non-Small Cell Lung Cancer Patients

Oncotarget
Oncology
2017English

Anti-Cd19 Chimeric Antigen Receptor T Cells in Combination With Nivolumab Are Safe and Effective Against Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Frontiers in Oncology
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy